| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |